Peptlas open data: peptide regulatory status by jurisdiction

Where peptides such as BPC-157, TB-500, semaglutide and retatrutide stand with six authorities - the U.S. FDA, Australia's TGA, the UK's MHRA, the EU's EMA, Health Canada and WADA - as open, citable data from Peptlas, an independent regulatory-status reference that sells nothing.

Snapshot: verified 2026-09-22 (ET). Always-current version: peptlas.com/peptide-status-by-country/

This repository mirrors the live site daily. Releases are archived on Zenodo (doi:10.5281/zenodo.22965339), so every version stays citable.

Files

File	Contents	Rows
data/peptide-status-matrix.csv	Regulatory status by jurisdiction	114
data/peptide-regulatory-events.csv	Regulatory events log	23
data/peptide-advisory-votes.csv	FDA advisory committee votes	7
data/peptide-sources.csv	Source bibliography	184
data/peptide-status-matrix.json	The status grid with metadata and the status definitions	-
data/catalog.json	Machine-readable index of every file and column	-

All files join on slug.

The five states

Status is never reduced to legal / illegal. "In limbo" is the case the headlines miss: something moved on paper (a nomination, a removal from a restricted list, an advisory vote) but the legal status did not.

Value	Label	Meaning
compounding_legal	Compounding-legal	On the FDA 503A bulk-substances list; a licensed pharmacy may compound it. This is not the same as being an FDA-approved drug.
under_review	Under review	Actively before the FDA advisory committee; a decision is pending and the status can move.
in_limbo	In limbo	Moved on paper - nominated, removed from a restricted list, or recommended by an FDA committee - but not added to the 503A list. The headline implies a change; the legal status has not moved.
restricted	Restricted	Prescription-only, banned, controlled, or under active FDA enforcement.
unscheduled	Unscheduled	No specific federal action; unaddressed at this time.

Each authority answers a slightly different legal question: the FDA column is about pharmacy compounding under Section 503A, Australia is scheduling under the Poisons Standard, the UK and EU are marketing authorisation, Canada is authorization and the Prescription Drug List, and WADA is the sport rulebook. See how to read each column.

Columns

Regulatory status by jurisdiction - peptide-status-matrix.csv

One row per compound and authority: the current status under the U.S. FDA, Australia (TGA), the UK (MHRA), the EU (EMA), Health Canada and WADA, in a five-state taxonomy, with a plain-language note.

Column	Meaning
compound	Compound name as used on Peptlas.
slug	Stable identifier; joins the other files.
jurisdiction	Authority, e.g. "United States (FDA)".
regulator	Short regulator name: FDA, TGA, MHRA, EMA, Health Canada, WADA.
status	compounding_legal
status_label	Human label for status.
note	What the status means for this compound under this authority.
entry_url	The Peptlas entry, with every primary source.
last_verified	Date (ET) the row was last verified by hand against primary sources.

Regulatory events log - peptide-regulatory-events.csv

Dated regulatory events for the tracked compounds (list removals, advisory votes, comment deadlines, enforcement), each with a neutral one-line summary and its primary source.

Column	Meaning
date	Event date (ET).
compound	Compound name.
slug	Joins the other files.
tag	not_legalized
summary	What happened, and what it did not change.
source_url	Primary or best-available source for the event.
id	Stable event identifier.

FDA advisory committee votes - peptide-advisory-votes.csv

Pharmacy Compounding Advisory Committee votes on the tracked compounds. Advisory votes do not change legal status. Where the FDA has not published minutes, tallies are as reported and the reporting source is named.

Column	Meaning
compound	Compound name.
slug	Joins the other files.
date	Vote date (ET).
committee	The committee that voted.
question	The question put to the committee.
outcome	recommended
yes	Yes votes (as reported where noted).
no	No votes.
abstain	Abstentions.
tally_source	Who reported the tally, while official minutes are unpublished.
us_status_now	The compound's current U.S. status - a vote alone never moves it.

Source bibliography - peptide-sources.csv

Every source cited by a Peptlas entry: regulator publications, dockets, warning letters and the reporting behind them, with what each one establishes.

Column	Meaning
compound	Compound name.
slug	Joins the other files.
label	Source title as cited.
url	Source URL.
note	What the source is cited for, where recorded.

How it is collected

Every row comes from a primary regulator publication (Federal Register, fda.gov, regulations.gov, the Poisons Standard, MHRA, EMA, Health Canada, WADA) and is verified by a person before it publishes. The U.S. sources are checked every six hours; the international jurisdictions change far less often and are re-verified in a monthly sweep. Tallies of advisory votes are labelled as reported until the FDA publishes official minutes. Full method: peptlas.com/methodology.

Cite

Peptlas Research Team (2026). Peptlas open data: peptide regulatory status by jurisdiction (Version 2026.09.22) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22965339

Machine-readable: CITATION.cff.

License

CC BY 4.0. Copy, chart and republish it, commercially too - credit Peptlas and link to peptlas.com/peptide-status-by-country/.

Not advice

Informational only - not medical or legal advice, and no health claim. Peptlas sells nothing, takes no money from vendors, and never suggests doses. Always confirm against the linked primary source.

Corrections

Found an error? Open an issue here or write to research@peptlas.com. Corrections are published on the site's changelog.